首页> 外文OA文献 >Primary Type3 (Non-ABC, Non-GCB) Subtype of Extranodal Diffuse Large B-Cell Lymphoma of the Thyroid Bearing No MYD88 Mutation by Padlock Probe Hybridization

【2h】

Primary Type3 (Non-ABC, Non-GCB) Subtype of Extranodal Diffuse Large B-Cell Lymphoma of the Thyroid Bearing No MYD88 Mutation by Padlock Probe Hybridization

机译：原发性3型（非aBC，非GCB）甲状腺结外弥漫性大B细胞淋巴瘤亚型通过挂锁探针杂交无mYD88突变

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Yukiko Nishi; Riko Kitazawa; Ryuma Haraguchi; Ayaka Ouchi; Yasuo Ueda; Yuri Kamaoka; Ken Yamamoto; Yasuhiko Todo; Hiroaki Miyaoka; Sohei Kitazawa;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Primary Type3 (Non-ABC, Non-GCB) Subtype of Extranodal Diffuse Large B-Cell Lymphoma of the Thyroid Bearing No MYD88 Mutation by Padlock Probe Hybridization [J] . Ouchi A, Todo Y, Ueda Y, Case Reports in Oncology . 2017,第2期

机译：甲状腺结外弥漫性大B细胞淋巴瘤的原发性3型（非ABC，非GCB）亚型，未通过挂锁探针杂交携带MYD88突变。
2. High response rate and improvement of long-term survival with combined treatment modalities in patients with poor-risk primary thyroid diffuse large B-cell lymphoma: an International Extranodal Lymphoma Study Group and Intergruppo Italiano Linfomi study. [J] . Mian M, Gaidano G, Conconi A, Leukemia and lymphoma . 2011,第5期

机译：高危原发性甲状腺弥漫性大B细胞淋巴瘤患者的高响应率和长期联合治疗方式的改善：国际淋巴结外淋巴瘤研究小组和Intergruppo Italiano Linfomi研究。
3. Morphologic Patterns and the Correlation With MYD88 L265P, CD79B Mutations in Primary Adrenal Diffuse Large B-Cell Lymphoma [J] . Chen Zihang, Zou Yan, Liu Weiping, American Journal of Surgical Pathology . 2020,第4期

机译：形态学模式及其与MyD88 L265P的相关性，原发性肾上腺弥漫性大B细胞淋巴瘤中的CD79B突变
4. Mutational profile of Diffuse Large B-cell Lymphoma with central nervous system relapse: analysis of CBioPortal for Cancer Genomics database [C] . Elena Voropaeva, Olga Beresina, Tatyana Pospelova, Conference on Cognitive Sciences, Genomics and Bioinformatics . 2020

机译：弥漫性大B细胞淋巴瘤与中枢神经系统复发的突变特征：用于癌症基因组学数据库的CBioPortal分析
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. Primary Type3 (Non-ABC Non-GCB) Subtype of Extranodal Diffuse Large B-Cell Lymphoma of the Thyroid Bearing No MYD88 Mutation by Padlock Probe Hybridization [O] . Yukiko Nishi, Riko Kitazawa, Ryuma Haraguchi, 2017

机译：甲状腺结外弥漫性大型B细胞淋巴瘤的原发性3型（非ABC非GCB）亚型未通过挂锁探针杂交携带MYD88突变。
7. Oncogenic Mutations and Chromosomal Aberrations in Primary Extranodal Diffuse Large B-Cell Lymphomas of the Thyroid—A Study of 21 Cases [O] . Juliana Knief, Niklas Gebauer, Veronica Bernard, 2015

机译：雌激素突变和染色体畸变在甲状腺缩放大B细胞淋巴瘤的甲状腺 - A研究

相关主题

Primary Type3 (Non-ABC, Non-GCB) Subtype of Extranodal Diffuse Large B-Cell Lymphoma of the Thyroid Bearing No MYD88 Mutation by Padlock Probe Hybridization

著录项

相似文献

相关主题

期刊订阅